Hostname: page-component-7bb8b95d7b-l4ctd Total loading time: 0 Render date: 2024-09-07T16:19:35.187Z Has data issue: false hasContentIssue false

Progressive Supranuclear Palsy

Published online by Cambridge University Press:  29 January 2018

B. Das*
Affiliation:
Lynfield Mount Hospital, Bradford BD9 6DP
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © Royal College of Psychiatrists, 1984 

References

Haldeman, S., Goldman, J. W., Hyde, J. & Pribram, H. F. (1981) Progressive supranuclear palsy, computed tomography and response to antiparkinsonian drugs. Neurology (NY), 31, 442–5.Google Scholar
Jackson, J. A., Jankovic, J. & Ford, J. (1983) Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Annals of Neurology, 13, 273–8.Google Scholar
Lishman, W. A. (1978) Progressive supranuclear palsy (Steele-Richardson Syndrome). Organic Psychiatry. Oxford: Blackwell.Google Scholar
Neophytides, A., Lieberman, A. N., Goldstein, M., Gopinathan, G., Leibowitz, M., Bock, J. & Walker, R. (1982) The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psychiatry, 45, 261–3.CrossRefGoogle ScholarPubMed
Scott, R. B. (Ed.) (1978) Price's Textbook of the Practice of Medicine 12th Edition. Oxford University Press.Google Scholar
Steele, J. C., Richardson, J. C. & Olszeweski, J. (1964) Progressive supranuclear palsy. Archives of Neurology, 10, 333–59.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.